Pancreatic Cancer Treatment Market

1
Pancreatic Cancer Treatment Market Size, Share
Trends Analysis Report and Segment Forecast,
2025 Grand View Research, Inc
The rising prevalence of obesity, alcohol
consumption, and smoking is expected to propel
the Pancreatic Cancer Treatment market growth. .
The global Pancreatic Cancer Treatment Market is
expected to reach USD 4.2 billion in 2025,
according to a new report by Grand View
Research, Inc. Increasing tobacco consumption,
smoking, obesity, and growing awareness
pertaining to various treatment options available
are propelling the market growth at a global
level. The peak incidence of pancreatic cancer
is seen in the age group of 65 to 75 years. Thus,
growing geriatric population is also expected to
drive the growth during the forecast
period. According to an article published in the
National Center for Biotechnology Information in
2015, pancreatic cancer is one of the most
dangerous malignancies and is the fourth most
common cause of cancer deaths in the U.S.
Furthermore, pancreatic cancer is expected to be
the second common cause of death in the U.S., by
2030. These factors together would propel the
market growth in the forecast period. To request
a sample copy or view summary of this report,
click the link below http//www.grandviewresearch
.com/industry-analysis/pancreatic-cancer-treatment
-market Further key findings from the study
suggest
2

• The study suggests that exocrine cancer is by far
  the most common type of pancreatic cancer
  accounting for more than 95 of the overall
  pancreatic cancer types
• Among the treatment types, targeted therapy
  occupied the largest share since it is considered
  as the most effective treatment option, which
  blocks the growth and spread of cancer cells
  without damaging healthy cells
• North America dominated the segment with the
  largest revenue share in 2015 due to high
  adoption rate of advanced treatment options and
  highly developed healthcare infrastructure
• Asia Pacific is anticipated to show a significant
  growth during the forecast period, mainly due to
  increasing government initiatives, growing
  awareness regarding the treatment options for
  pancreatic cancer, and the availability of
  highly sophisticated medical infrastructure for
  effective treatment
• Some of the major companies operating in this
  market are, but are not limited to, Eli Lilly and
  Company Celgene Corporation F. Hoffmann-La
  Roche AG Amgen, Inc. Novartis AG PharmaCyte
  Biotech, Inc. Clovis Oncology Teva
  Pharmaceutical Industries Ltd. Merck Co.,
  Inc. and Pfizer, Inc.
• Grand View Research has segmented the pancreatic
  cancer treatment market on the basis of affected
  region, treatment, and region
• Pancreatic Cancer Treatment Affected Region
  Outlook (Revenue, USD Million, 2014 - 2025)
• Exocrine
• Endocrine
• Pancreatic Cancer Treatment Outlook (Revenue, USD
  Million, 2014 - 2025)
• Chemotherapy
• Targeted Therapy

3

• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil

4

• Table of Content of Pancreatic Cancer Treatment
  Market
• Chapter 1 Research Methodology
• Information Procurement
• Data Analysis
• Approaches for Market Estimation
• Approach 1 Demand analysis bottom-up approach
• Approach 2 Top-down market estimation
• Approach 3 Commodity flow and bottom-up market
  estimation
• Approach 4 KoL perspective-based market sizing
• Chapter 2 Executive Summary
• 2.1 Market Snapshot
• Chapter 3 Pancreatic Cancer Treatment Market
  Variables, Trends Scope
• Market Segmentation
• Market Size and Growth Prospects
• Market driver analysis
• Market restraint analysis
• Key Opportunities Prioritized
• Industry Analysis Porters

5

• 5.3.1 Market estimates and forecasts, 2014 - 2025
  (USD Million)
• 5.4 Others
• 5.4.1 Market estimates and forecasts, 2014 - 2025
  (USD Million)
• Chapter 6 Pancreatic Cancer Treatment Market
  Regional Estimates Trend Analysis, by Affected
  region Application
• Pancreatic Cancer Treatment Market Share by
  Region, 2015 2025
• North America
• U.S.
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025
• Canada
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025
• Europe
• U.K.
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025
• Germany
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025

6

• Mexico
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025
• MEA
• South Africa
• Market estimates and forecasts, by affected
  region, 2014 - 2025
• Market estimates and forecasts, by application,
  2014 - 2025
• Chapter 7 Competitive Landscape
• Strategy framework
• Company Profiles
• Eli Lily and Company
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Celgene Corporation
• Company overview
• Financial performance
• Product benchmarking

7

• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• PharmaCyte Biotech, Inc.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Clovis Oncology
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Teva Pharmaceutical Industries Ltd.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives

8
About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA Grand View Research, Inc Phone
1-415- 349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/